Why did the HPA request the AGNIR to produce a report on power frequency electromagnetic fields, melatonin and the risk of breast cancer?
There have been concerns that exposure to electromagnetic fields (EMFs) might increase the risk of breast cancer. In particular, the “melatonin hypothesis” attempts to link long-term exposure to EMFs (and to light at night) with increased risk of breast cancer via a reduction in the hormone melatonin. The report considers the relevant scientific evidence for the melatonin hypothesis in relation to breast cancer. Breast cancer development is influenced by various hormonal factors and these could be influenced by exposure to EMFs. This disease was viewed as providing valuable information on the mechanisms that could give rise to cancer induction in organs and tissues following exposure to power frequency EMFs. A variety of factors are believed to affect the production of melatonin in humans, including alcohol and oral contraceptives, as well as various drugs and medicines. Changes in the timing or extent of melatonin production may affect the risk of other diseases, in addition to breast
Related Questions
- Why did the HPA request the AGNIR to produce a report on power frequency electromagnetic fields, melatonin and the risk of breast cancer?
- What is the scope and coverage of the AGNIR report on power frequency electromagnetic fields, melatonin and the risk of breast cancer?
- Why did the AGNIR report on power frequency electromagnetic fields, melatonin and the risk of breast cancer call for more research?
